Original Publication Date: >14 August, 2015
Publication / Source: Future Neurology
Authors: Tejas Sankar
The incidence of Alzheimer’s disease (AD) is increasing as the world’s population ages, and will double in the next 20 years . Unfortunately, despite immense investment of research effort and capital into pharmacological approaches, no drug has yet been developed that consistently yields a significant and lasting clinical benefit in AD sufferers. In this context, novel approaches to treating AD may help respond to a critical unmet need while the quest for effective drugs continues .